GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CSBR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Champions Oncology stock downgraded from Hold/Accumulate to Sell Candidate after Friday trading session.
(Updated on Apr 19, 2024)

Sell candidate since Apr 19, 2024 PDF

The Champions Oncology stock price fell by -0.0987% on the last day (Friday, 19th Apr 2024) from $5.07 to $5.06. During the last trading day the stock fluctuated 0.791% from a day low at $5.06 to a day high of $5.10. The price has been going up and down for this period, and there has been a 4.12% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -252 shares and in total, 953 shares were bought and sold for approximately $4.82 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $5.16 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -21.15% during the next 3 months and, with a 90% probability hold a price between $3.66 and $4.07 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CSBR Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 05, 2024, and so far it has risen 4.12%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Champions Oncology stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $5.23. On a fall, the stock will find some support from the short-term average at $5.04. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Champions Oncology stock

Champions Oncology finds support from accumulated volume at $5.02 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0400 between high and low, or 0.791%. For the last week the stock has had daily average volatility of 0.93%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CSBR) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Champions Oncology to open at $5.07, and during the day (based on 14 day Average True Range), to move between $4.90 and $5.22, which gives a possible trading interval of +/-$0.161 (+/-3.17%) up or down from last closing price. If Champions Oncology takes out the full calculated possible swing range there will be an estimated 6.34% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $5.02 (0.79%) than the resistance at $5.50 (8.70%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Champions Oncology stock A Buy?

Champions Oncology holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.114 Sell Candidate Downgraded

Predicted Opening Price for Champions Oncology of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$5.07 ( 0.264%) $5.06

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CSBR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.11 1.05 %
R2 5.10 0.752 %
R1 5.09 0.565 %
Current price: 5.06
Support S1 5.06 -0.0385 %
S2 5.05 -0.225 %
S3 5.03 -0.527 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.81 14.82 %
R2 5.70 12.65 %
R1 5.50 8.70 %
Current price 5.06
Support S1 5.02 -0.791%
S2 5.00 -1.19%
S3 4.98 -1.58%

FAQ

What is the symbol for Champions Oncology Stock and on which exchange is it traded?
The symbol for Champions Oncology is CSBR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Champions Oncology Stock?
Champions Oncology holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Champions Oncology Stock?
Champions Oncology Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Champions Oncology Stock.

What's the current price of Champions Oncology Stock?
As of the end of day on the 2024-04-19, the price of an Champions Oncology (CSBR) share was $5.06.

What is the 52-week high and low for Champions Oncology Stock?
The 52-week high for Champions Oncology Stock is $7.32 and the 52-week low is $4.17.

What is the market capitalization of Champions Oncology Stock?
As of the 2024-04-19, the market capitalization of Champions Oncology is 68.785M.

When is the next earnings date for Champions Oncology?
The upcoming earnings date for Champions Oncology is Jul 22, 2024.
Click to get the best stock tips daily for free!

About Champions Oncology

Champions Oncology Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune... CSBR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT